Highlights

  • SkinKandy (ASX:SK1) shares closed at A$2.45 on 17 August 2026, down 8.92%.
  • The company is scheduled to release its maiden FY26 results on 25 August 2026.
  • Prospectus forecasts targeted FY26 Revenue of A$88.7 million and EBITDA of A$23.5 million.
  • SkinKandy had reached 100 stores across Australia and New Zealand by December 2025.

SkinKandy Limited (ASX:SK1) enters its first reporting season as a listed company with investors watching whether its store rollout and operating model are developing in line with the forecasts outlined at its IPO. The shares closed at A$2.45 on 17 August 2026, down 8.92%, without a fresh company announcement accompanying the decline. The upcoming FY26 result will provide the first listed-company scorecard for revenue, profitability, store growth and underlying retail performance.

Why are the shares under pressure?

SkinKandy shares closed at A$2.45 on 17 August 2026, down 8.92% on the day. No company-specific announcement was identified on 17 August that provides a direct explanation for the decline.

The latest material company disclosure was the 7 August announcement confirming that FY26 results will be released on Tuesday, 25 August 2026, with an investor and analyst conference call at 11:00 AEST.

The timing makes the share-price decline particularly relevant because SkinKandy has not yet reported a full financial year as an ASX-listed company. Investors are therefore preparing to compare the company's first listed results with the financial forecasts contained in its prospectus.

What happened?

SkinKandy listed on the ASX on 21 May 2026 at an Offer Price of A$2.20 per share, raising approximately A$160 million.

The company had established a network of 100 stores across Australia and New Zealand by December 2025, compared with roughly 50 stores in June 2023.

The Business has expanded through a combination of piercing services, fashion jewellery and aftercare products. More than 750 trained piercers operate across the network, while the company offers more than 60 piercing types.

The latest major corporate disclosure before results was a substantial-holder notice from the Wilson Asset Management group in July, covering 5.19% of the company.

The numbers investors need to know

Prospectus forecasts provide the key benchmark for the 25 August result:

  • FY23 revenue: A$38.6 million
  • FY24 revenue: A$51.7 million
  • FY25 revenue: A$70.1 million
  • FY26 forecast revenue: A$88.7 million
  • FY23 EBITDA: A$9.4 million
  • FY24 EBITDA: A$12.9 million
  • FY25 EBITDA: A$17.5 million
  • FY26 forecast EBITDA: A$23.5 million
  • FY23 NPAT: A$3.4 million
  • FY24 NPAT: A$4.8 million
  • FY25 NPAT: A$6.4 million
  • FY26 forecast NPAT: A$8.6 million
  • FY25 average store payback: approximately 13.9 months
  • Target network: 180–210 stores across Australia and New Zealand

Statutory FY25 figures compiled by Market Index showed revenue of approximately A$71.8 million, EBITDA of A$19.8 million and NPAT of A$8.1 million. The FY26 accounts should provide the first audited reconciliation between reported results and the prospectus presentation.

Why this matters

SkinKandy has built a specialty retail model around piercing services rather than relying solely on jewellery sales. Piercing accounted for 52% of the prospectus revenue mix, fashion jewellery 39% and aftercare products 9%.

The model also depends heavily on store economics. A store payback period of approximately 13.9 months in FY25 suggests relatively rapid Capital recycling, which supports the company's ability to expand its store footprint.

The first listed financial result will therefore be important beyond the headline revenue number. Investors will want to understand comparable-store sales, margins, new-store performance and whether the existing network continues to generate the Economics assumed in the expansion strategy.

The bull case

SkinKandy's historical growth provides a clear expansion framework. Prospectus revenue increased from A$38.6 million in FY23 to A$70.1 million in FY25, while EBITDA increased from A$9.4 million to A$17.5 million.

The company's store network has also doubled from approximately 50 locations in June 2023 to 100 by December 2025. Reaching the stated 180–210 store target would create further scope for revenue growth across Australia and New Zealand.

The business has also developed a specialised workforce, with more than 750 trained piercers, while chief executive Dain Friis brings previous experience with large-scale jewellery retail expansion.

The bear case

The immediate risk is execution against the prospectus expectations. SkinKandy is being assessed on its first set of results as a listed company, leaving limited historical market reporting to establish how the business performs through different retail conditions.

The planned expansion to 180–210 stores requires continued access to suitable locations, landlord agreements and trained piercers. Rapid recruitment and store openings could also place pressure on service consistency.

Consumer spending remains another consideration. A piercing and jewellery purchase may be relatively affordable compared with larger discretionary purchases, but younger consumers remain exposed to cost-of-living pressures.

Expansion outside Australia and New Zealand would also introduce greater operational complexity than the company's established market footprint.

What could move the ASX share next?

The FY26 result and investor conference call on 25 August 2026 are the defining near-term events.

Investors will focus on whether revenue reached the prospectus forecast of A$88.7 million and EBITDA approached A$23.5 million. Store count at 30 June, comparable-store sales, gross margin, cash or debt, Capital Expenditure and any FY27 guidance will also be important.

The market will particularly look for evidence that new stores continue to achieve the approximately 14-month payback period recorded in FY25.

Outlook

SkinKandy (ASX:SK1) enters its first reporting season with a substantial store network and a history of revenue and EBITDA growth, but the 17 August 2026 share-price decline of 8.92% highlights the sensitivity surrounding the upcoming result. The company now needs to demonstrate that its FY26 performance is tracking the prospectus expectations and that store-level economics remain intact as the network expands. The 25 August results should provide the first detailed assessment of comparable sales, margins, profitability and the pace at which SkinKandy can continue its rollout.